Lack of association between the rs2294008 polymorphism in the prostate stem cell antigen gene and colorectal neoplasia: A case-control and immunohistochemical study

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Smith, Christopher ^a   Lochhead, Paul ^a   Basavaraju, Umesh ^a   Hold, Georgina L ^a   Fyfe, Nicky ^b   Murray, Graeme I ^b   El Omar, Emad M ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Adenoma; Case control study; Colon cancer; Colorectal cancer; Colorectal neoplasia; Immunohistochemistry; Polyp; Prostate stem cell antigen; Rectal cancer; Single nucleotide polymorphism

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; PSCA PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR PROTEIN;

ARTICLE; CASE CONTROL STUDY; COLORECTAL TUMOR; GENETIC POLYMORPHISM; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE;

ANTIGENS, NEOPLASM; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; GPI-LINKED PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC;

EID: 84869469872     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-371     Document Type: Article

References (29)

1. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Reiter RE, Gu Z, Watabe T, Thomas G, Szigeti K, Davis E, Wahl M, Nisitani S, Yamashiro J, Le Beau MM, Loda M, Witte ON, Proc Natl Acad Sci U S A 1998 95 4 1735 1740 10.1073/pnas.95.4.1735 9465086 (Pubitemid 28103463)
2. Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Gu Z, Thomas G, Yamashiro J, Shintaku IP, Dorey F, Raitano A, Witte ON, Said JW, Loda M, Reiter RE, Oncogene 2000 19 10 1288 1296 10.1038/sj.onc.1203426 10713670 (Pubitemid 30160621)
3. Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer. Han KR, Seligson DB, Liu X, Horvath S, Shintaku PI, Thomas GV, Said JW, Reiter RE, J Urol 2004 171 3 1117 1121 10.1097/01.ju.0000109982.60619.93 14767283 (Pubitemid 38327539)
4. Expression of PSCA, PIWIL1, and TBX2 in endometrial adenocarcinoma. Liu WK, Jiang XY, Zhang ZX, Onkologie 2010 33 5 241 245 10.1159/000305098 20502058
5. The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis. Elsamman EM, Fukumori T, Tanimoto S, Nakanishi R, Takahashi M, Toida K, Kanayama HO, BJU Int 2006 98 3 668 673 10.1111/j.1464-410X.2006.06350.x 16925770 (Pubitemid 44185896)
6. Expression of mesothelin, fascin, and prostate stem cell antigen in primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous tumors from metastatic pancreatic mucinous carcinomas in the ovary. Cao D, Ji H, Ronnett BM, Int J Gynecol Pathol 2005 24 1 67 72 15626919 (Pubitemid 40066455)
7. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma. Amara N, Palapattu GS, Schrage M, Gu Z, Thomas GV, Dorey F, Said J, Reiter RE, Cancer Res 2001 61 12 4660 4665 11406532 (Pubitemid 32691871)
8. Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Argani P, Rosty C, Reiter RE, Wilentz RE, Murugesan SR, Leach SD, Ryu B, Skinner HG, Goggins M, Jaffee EM, Yeo CJ, Cameron JL, Kern SE, Hruban RH, Cancer Res 2001 61 11 4320 4324 11389052 (Pubitemid 32685751)
9. Clinical significance of prostate stem cell antigen expression in non-small cell lung cancer. Kawaguchi T, Sho M, Tojo T, Yamato I, Nomi T, Hotta K, Hamada K, Suzaki Y, Sugiura S, Kushibe K, Nakajima Y, Taniguchi S, Jpn J Clin Oncol 2010 40 4 319 326 10.1093/jjco/hyp181 20085909
10. The prostate stem cell antigen represents a novel glioma-associated antigen. Geiger KD, Hendruschk S, Rieber EP, Morgenroth A, Weigle B, Juratli T, Senner V, Schackert G, Temme A, Oncol Rep 2011 26 1 13 21 21503583
11. Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Sakamoto H, Yoshimura K, Saeki N, Katai H, Shimoda T, Matsuno Y, Saito D, Sugimura H, Tanioka F, Kato S, Matsukura N, Matsuda N, Nakamura T, Hyodo I, Nishina T, Yasui W, Hirose H, Hayashi M, Toshiro E, Ohnami S, Sekine A, Sato Y, Totsuka H, Ando M, Takemura R, Takahashi Y, Ohdaira M, Aoki K, Honmyo I, Chiku S, Aoyagi K, Sasaki H, Ohnami S, Yanagihara K, Yoon KA, Kook MC, Lee YS, Park SR, Kim CG, Choi IJ, Yoshida T, Nakamura Y, Hirohashi S, Study Group of Millennium Genome Project for Cancer, Nat Genet 2008 40 6 730 740 10.1038/ng.152 18488030 (Pubitemid 351748870)
12. Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors. Bahrenberg G, Brauers A, Joost HG, Jakse G, Biochem Biophys Res Commun 2000 275 3 783 788 10.1006/bbrc.2000.3393 10973799
13. Prostate stem cell antigen, a presumable organ-dependent tumor suppressor gene, is down-regulated in gallbladder carcinogenesis. Ono H, Hiraoka N, Lee YS, Woo SM, Lee WJ, Choi IJ, Saito A, Yanagihara K, Kanai Y, Ohnami S, Chiwaki F, Sasaki H, Sakamoto H, Yoshida T, Saeki N, Genes Chromosomes Cancer 2012 51 1 30 41 10.1002/gcc.20928 21936014
14. Prostate stem cell antigen: a Jekyll and Hyde molecule? Saeki N, Gu J, Yoshida T, Wu X, Clin Cancer Res 2010 16 14 3533 3538 10.1158/1078-0432.CCR-09- 3169 20501618
15. Genetic variation in the prostate stem cell antigen gene and upper gastrointestinal cancer in white individuals. Lochhead P, Frank B, Hold GL, Rabkin CS, Ng MT, Vaughan TL, Risch HA, Gammon MD, Lissowska J, Weck MN, Raum E, Muller H, Illig T, Klopp N, Dawson A, McColl KE, Brenner H, Chow WH, El-Omar EM, Gastroenterology 2011 140 2 435 441 10.1053/j.gastro.2010.11.001 21070776
16. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, Int J Cancer 2010 127 12 2893 2917 10.1002/ijc.25516 21351269
17. The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers. Jeffery N, McLean MH, El-Omar EM, Murray GI, Histopathology 2009 54 7 820 828 10.1111/j.1365-2559.2009.03301.x 19635101
18. COX-2 expression in sporadic colorectal adenomatous polyps is linked to adenoma characteristics. McLean MH, Murray GI, Fyfe N, Hold GL, Mowat NA, El-Omar EM, Histopathology 2008 52 7 806 815 10.1111/j.1365-2559.2008.03038.x 18462368 (Pubitemid 351724910)
19. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia. Zhao Z, Liu J, Li S, Shen W, Prostate 2009 69 12 1292 1302 10.1002/pros.20973 19462463
20. Peripheral blood reverse transcription PCR assay for prostate stem cell antigen correlates with androgen-independent progression in advanced prostate cancer. Zhao Z, Zeng G, Ma W, Ou L, Liang Y, Int J Cancer 2011 131 4 902 910 21952944
21. Prostate stem cell antigen mRNA in peripheral blood as a potential predictor of biochemical recurrence in high-risk prostate cancer. Joung JY, Cho KS, Kim JE, Seo HK, Chung J, Park WS, Choi MK, Lee KH, J Surg Oncol 2010 101 2 145 148 20039280
22. Genetic variant in PSCA predicts survival of diffuse-type gastric cancer in a Chinese population. Wang M, Bai J, Tan Y, Wang S, Tian Y, Gong W, Zhou Y, Gao Y, Zhou J, Zhang Z, Int J Cancer 2011 129 5 1207 1213 10.1002/ijc.25740 21064099
23. Growth delay of human bladder cancer cells by Prostate Stem Cell Antigen downregulation is associated with activation of immune signaling pathways. Marra E, Uva P, Viti V, Simonelli V, Dogliotti E, De Rinaldis E, Lahm A, La Monica N, Nicosia A, Ciliberto G, Palombo F, BMC Cancer 2010 10 129 10.1186/1471-2407-10- 129 20374648
24. Tissue expression, structure and function of the murine Ly-6 family of molecules. Gumley TP, McKenzie IF, Sandrin MS, Immunol Cell Biol 1995 73 4 277 296 10.1038/icb.1995.45 7493764
25. Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda. Chimienti F, Hogg RC, Plantard L, Lehmann C, Brakch N, Fischer J, Huber M, Bertrand D, Hohl D, Hum Mol Genet 2003 12 22 3017 3024 10.1093/hmg/ddg320 14506129 (Pubitemid 37442029)
26. Immune system expression of SLURP-1 and SLURP-2, two endogenous nicotinic acetylcholine receptor ligands. Moriwaki Y, Yoshikawa K, Fukuda H, Fujii YX, Misawa H, Kawashima K, Life Sci 2007 80 24-25 2365 2368 17286989 (Pubitemid 46818253)
27. Prostate stem cell antigen is an endogenous lynx1-like prototoxin that antagonizes alpha7-containing nicotinic receptors and prevents programmed cell death of parasympathetic neurons. Hruska M, Keefe J, Wert D, Tekinay AB, Hulce JJ, Ibanez-Tallon I, Nishi R, J Neurosci 2009 29 47 14847 14854 10.1523/JNEUROSCI.2271-09.2009 19940180
28. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Livak KJ, Genet Anal 1999 14 5-6 143 149 10084106 (Pubitemid 29095371)
29. The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. Sabattini E, Bisgaard K, Ascani S, Poggi S, Piccioli M, Ceccarelli C, Pieri F, Fraternali-Orcioni G, Pileri SA, J Clin Pathol 1998 51 7 506 511 10.1136/jcp.51.7.506 9797726 (Pubitemid 28375029)